MZMinmin Zhang

Minmin Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Minmin Zhang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Spillover Effect of Suspending Nonessential Surgery: Evidence from Kidney Transplantation

    by Minmin Zhang, Guihua Wang, Tinglong Dai

    Kidney transplantation is a life-saving procedure for patients with end-stage kidney disease. A delay in kidney transplantation has serious, even life-threatening, consequences. This study examines the impact of suspending nonessential surgery on deceased-donor kidney transplantation. Between March and April 2020, amid the COVID-19 pandemic, multiple states in the United States temporarily suspended nonessential surgery. Although these suspensions were not intended for deceased-donor kidney transplantation, because it is an essential surgery, the literature on service operations implies such suspensions may have either a positive or a negative spillover effect, depending on whether hospitals maintain or reduce resources. Motivated by these divergent implications, we estimate the potential spillover effect of suspending nonessential surgery on deceased-donor kidney transplantation. Analyzing a data set of all U.S. kidney transplant procedures, we observe a steep decline in transplant volume during the early months of the pandemic, with states that suspended nonessential surgery experiencing steeper declines. Using a difference-in-differences approach, we estimate a 13% reduction in transplant volume due to state-level suspension of nonessential surgery. This negative spillover effect is particularly pronounced in low-efficiency transplant centers with long cold ischemia times (CITs) but less so in high-efficiency centers, suggesting CIT is a key indicator of operational resilience against disruptions. Our mediation analysis reveals more than 40% of the spillover effect is attributable to changes in healthcare employment. This study indicates that in future public health crises, policymakers should adopt nuanced strategies to secure the healthcare workforce essential for supporting critical services, especially in centers with longer CITs. This paper was accepted by Jayashankar Swaminathan, operations management. Funding: This work was supported by the Johns Hopkins Bloomberg School of Public Health [Hopkins Business of Health Initiative seed grant, “COVID-19 and the Business of Health”]. Supplemental Material: The online appendix and data files are available at https://doi.org/10.1287/mnsc.2023.03624 .

  • Open Access

    Pausing transplants in the face of a global pandemic: Patient survival implications

    by Minmin Zhang, Guihua Wang, Jun Li, Wallace J. Hopp, David D. Lee

    The coronavirus disease 2019 (COVID‐19) pandemic has disrupted normal operating procedures at transplant centers. With the possibility that COVID‐19 infection carries an overall 4% mortality rate and potentially a 24% mortality rate among the immunocompromised transplant recipients, many transplant centers considered the possibility of slowing down and even potentially pausing all transplants. Many proposals regarding the need for pausing organ transplants exist; however, much remains unknown. Whereas the impact of the COVID‐19 pandemic on the overall healthcare system is unknown, the potential impact of pausing organ transplants over a period can be estimated. This study presents a model for evaluating the impact of pausing liver transplants over a spectrum of model for end‐stage liver disease‐sodium (MELD‐Na) scores. Our model accounts for two potential risks of a pause: (1) the waitlist mortality of all patients who do not receive liver transplants during the pause period, and (2) the impact of a longer waiting list due to the pause of liver transplants and the continuous accrual of new patients. Using over 12 years of liver transplant data from the United Network for Organ Sharing and a system of differential equations, we estimate the threshold probability above which a decision maker should pause liver transplants to reduce the loss of patient life months. We also compare different pause policies to illustrate the value of patient‐specific and center‐specific approaches. Finally, we analyze how capacity constraints affect the loss of patient life months and the length of the waiting list. The results of this study are useful to decision makers in deciding whether and how to pause organ transplants during a pandemic. The results are also useful to patients (and their care providers) who are waiting for organ transplants.